Outset Medical, Inc.

Symbol: OM




Market price today

  • -0.9862

    P/E Ratio

  • 0.0130

    PEG Ratio

  • 112.12M

    MRK Cap

  • 0.00%

    DIV Yield

Outset Medical, Inc. (OM) Stock Price & Analysis

Shares Outstanding


Gross Profit Margin


Operating Profit Margin


Net Profit Margin


Return on Assets


Return on Equity


Return on Capital Employed


Company general description and statistics

Sector: Healthcare
Industry: Medical Devices
CEO:Ms. Leslie L. Trigg
Full-time employees:480
City:San Jose
Address:3052 Orchard Drive

Outset Medical, Inc., a medical technology company, develops a hemodialysis system for dialysis. It provides the Tablo Hemodialysis System, which comprises a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.

General Outlook

When we look at how much money they make before expenses, they keep 0.246% as profit. This shows they're good at controlling costs and are financially stable. Their operating profit, which is money made from regular business activities, is -1.305%. This means they run their business efficiently. Lastly, after paying all their bills, they still have a profit of -1.349%. This tells us they're good at keeping money after all costs.

Return on Investments

The company's asset efficiency, represented by a robust -0.487% return, is a testament to Outset Medical, Inc.'s adeptness in optimizing resource deployment. Outset Medical, Inc.'s utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of -1.225%. Furthermore, the proficiency of Outset Medical, Inc. in capital utilization is underscored by a remarkable -0.552% return on capital employed.

Liquidity Ratios

Analyzing OM liquidity ratios reveals its financial health of the firm. The current ratio of 642.18% gauges short-term asset coverage for liabilities. The quick ratio (519.83%) assesses immediate liquidity, while the cash ratio (63.50%) indicates cash reserves.

Current Ratio642.18%
Quick Ratio519.83%
Cash Ratio63.50%

Profitability Ratios

OM profitability indicators offer a lens into its earnings landscape. A pretax profit margin of -134.54% underscores its earnings before tax deductions. The effective tax rate stands at -0.29%, revealing its tax efficiency. The net income per EBT, 100.29%, and the EBT per EBIT, 103.11%, provide insights into its earnings hierarchy. Lastly, with an EBIT per revenue ratio of -130.48%, we grasp its operational profitability.

Pretax Profit Margin-134.54%
Effective Tax Rate-0.29%
Net Income per EBT100.29%
EBT per EBIT103.11%
EBIT per Revenue-130.48%

Operational Efficiency

Operational metrics shed light on its business agility. With an operating cycle of 6.42, it details the span from stock purchase to revenue. The 5 days it takes to settle debts showcases its creditor relations. Meanwhile, a 1 cash conversion cycle and 342.88% receivables turnover rate reflect its cash flow efficiency and credit management, respectively.

Days of Sales Outstanding520
Days of Inventory Outstanding216
Operating Cycle322.60
Days of Payables Outstanding26
Cash Conversion Cycle296
Receivables Turnover3.43
Payables Turnover13.92
Inventory Turnover1.69
Fixed Asset Turnover7.37
Asset Turnover0.36

Cash Flow Ratios

Peering into the cash flow metrics reveals liquidity and operational efficiency. The operating cash flow per share, -2.60, and free cash flow per share, -2.66, depict cash generation on a per-share basis. The cash per share value, 4.46, showcases liquidity position. Lastly, the operating cash flow sales ratio, -1.06, offers insight into cash flow relative to sales.

Operating Cash Flow per Share-2.60
Free Cash Flow per Share-2.66
Cash per Share4.46
Operating Cash Flow Sales Ratio-1.06
Free Cash Flow to Operating Cash Flow Ratio1.02
Cash Flow Coverage Ratio-23.27
Short Term Coverage Ratio-80.71
Capital Expenditure Coverage Ratio-44.41
Dividend Paid and Capex Coverage Ratio-44.41

Debt and Leverage Ratios

Diving into debt and leverage metrics unveils the company's financial structure. The debt ratio, at 1.65%, highlights its total liabilities relative to assets. With a debt-equity ratio of 0.06, we discern the balance between debt and equity financing. The long-term debt to capitalization, 4.17%, and total debt to capitalization, 5.76%, ratios shed light on its capital structure. An interest coverage of -43.35 indicates its ability to manage interest expenses.

Debt Ratio1.65%
Debt Equity Ratio0.06
Long Term Debt to Capitalization4.17%
Total Debt to Capitalization5.76%
Interest Coverage-43.35
Cash Flow to Debt Ratio-23.27
Company Equity Multiplier3.72

Per Share Data

Speaking about the per share data offers a perceptive view of financial distribution. The revenue per share, 2.63, provides a glimpse into top-line earnings distributed across each share. Net income per share, -3.48, reflects the portion of profit attributed to each share. The book value per share, 2.48, represents the net asset value distributed per share, while the tangible book value per share, 2.48, excludes intangible assets.

Revenue Per Share2.63
Net Income Per Share-3.48
Book Value Per Share2.48
Tangible Book Value Per Share2.48
Shareholders Equity Per Share2.48
Interest Debt Per Share3.00
Capex Per Share-0.07

Growth Ratios

Delving into growth metrics provides a snapshot of financial expansion. The revenue growth rate, 13.00%, indicates top-line expansion, while the gross profit growth, 62.62%, reveals profitability trends. EBIT growth, -5.43%, and operating income growth, -5.43%, offer insights into operational profitability progression. The net income growth, -6.04%, showcases bottom-line expansion, and the EPS growth, -2.96%, measures the growth in earnings per share.

Revenue Growth13.00%
Gross Profit Growth62.62%
EBIT Growth-5.43%
Operating Income Growth-5.43%
Net Income Growth-6.04%
EPS Growth-2.96%
EPS Diluted Growth-2.96%
Weighted Average Shares Growth2.96%
Weighted Average Shares Diluted Growth2.96%
Operating Cash Flow Growth9.85%
Free Cash Flow Growth12.49%
10-Year Revenue Growth per Share3840.81%
5-Year Revenue Growth per Share3840.81%
3-Year Revenue Growth per Share124.94%
10-Year Operating CF Growth per Share-71.61%
5-Year Operating CF Growth per Share-71.61%
3-Year Operating CF Growth per Share-14.31%
10-Year Net Income Growth per Share-110.58%
5-Year Net Income Growth per Share-110.58%
3-Year Net Income Growth per Share-23.34%
10-Year Shareholders Equity Growth per Share125.89%
5-Year Shareholders Equity Growth per Share125.89%
3-Year Shareholders Equity Growth per Share-67.78%
Receivables Growth17.49%
Inventory Growth-4.39%
Asset Growth-21.57%
Book Value per Share Growth-51.48%
Debt Growth31.93%
R&D Expense Growth17.30%
SGA Expenses Growth8.82%

Other Metrics

Venturing into other key metrics unveils diverse facets of financial performance. The enterprise value, 335,950,080, captures the company's total value, considering both debt and equity. Income quality, 0.76, assesses the reliability of reported earnings. The sales, general, and administrative to revenue ratio, 0.35, gauges operational efficiency, while the research and development to revenue, 43.96%, highlights investment in innovation.

Enterprise Value335,950,080
Income Quality0.76
Sales General and Administrative to Revenue0.35
Research and Development to Revenue43.96%
Capex to Operating Cash Flow2.62%
Capex to Revenue-2.64%
Capex to Depreciation-59.21%
Stock-Based Compensation to Revenue29.63%
Graham Number13.94
Return on Tangible Assets-55.07%
Graham Net Net1.25
Working Capital235,896,000
Tangible Asset Value122,886,000
Net Current Asset Value100,304,000
Invested Capital1
Average Receivables30,525,000
Average Payables3,215,000
Average Inventory50,345,500
Days Sales Outstanding92
Days Payables Outstanding21
Days of Inventory On Hand177

Valuation Ratios

Exploring the valuation ratios offers insights into perceived market value. The price to book value ratio, 1.79, and the price to book ratio, 1.79, reflect the market's valuation relative to the company's book value. The price to sales ratio, 1.32, provides a perspective on valuation in relation to sales. Ratios like price to free cash flows, -1.22, and price to operating cash flows, -1.26, gauge market valuation against cash flow metrics.

Price Book Value Ratio1.79
Price to Book Ratio1.79
Price to Sales Ratio1.32
Price Cash Flow Ratio-1.26
Price Earnings to Growth Ratio0.01
Enterprise Value Multiple-1.24
Price Fair Value1.79
Price to Operating Cash Flow Ratio-1.26
Price to Free Cash Flows Ratio-1.22
Price to Tangible Book Ratio2.18
Enterprise Value to Sales2.58
Enterprise Value Over EBITDA-2.18
EV to Operating Cash Flow-2.56
Earnings Yield-64.41%
Free Cash Flow Yield-50.25%
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
Eugene Alexeev
NumFin Founder and investing enthusiast

Frequently Asked Question

How many company shares are outstanding in 2024?

There are stock number shares outstanding of Outset Medical, Inc. (OM) on the NASDAQ in 2024.

What is P/E ratio of enterprise in 2024?

The current P/E ratio of enterprise is -0.986 in 2024.

What is the ticker symbol of Outset Medical, Inc. stock?

The ticker symbol of Outset Medical, Inc. stock is OM.

What is company IPO date?

IPO date of Outset Medical, Inc. is 2020-09-15.

What is company current share price?

Current share price is 2.220 USD.

What is stock market cap today?

The market cap of stock today is 112122654.000.

What is PEG ratio in 2024?

The current 0.013 is 0.013 in 2024.

What is the number of employees in 2024?

In 2024 the company has 480.